Advertisement
U.S. Markets closed

Scopus BioPharma Inc. (SCPS)

OTC Markets EXMKT - OTC Markets EXMKT Delayed Price. Currency in USD
Visitors trend2W10W9M
0.00040.0000 (0.00%)
At close: 04:00PM EDT
Advertisement
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Total Revenue
0
0
0
0
0
Operating Expense
9,343
11,715
27,635
10,156
2,690
Operating Income
-9,343
-11,715
-27,635
-10,156
-2,690
Net Non Operating Interest Income Expense
-
0
-774.679
-706.446
0
Other Income Expense
-
-
1,456
-
-
Pretax Income
-9,343
-11,715
-26,953
-10,862
-2,690
Net Income Common Stockholders
-8,696
-11,610
-26,953
-10,862
-2,690
Diluted NI Available to Com Stockholders
-8,696
-11,610
-26,953
-10,862
-2,690
Basic EPS
-0.31
-0.55
-1.56
-0.81
-0.18
Diluted EPS
-0.31
-0.55
-1.56
-0.81
-0.18
Basic Average Shares
28,088
21,094
17,252
13,363
14,976
Diluted Average Shares
28,088
21,094
17,252
13,363
14,976
Total Operating Income as Reported
-
-11,715
-27,635
-10,156
-2,690
Total Expenses
9,343
11,715
27,635
10,156
2,690
Net Income from Continuing & Discontinued Operation
-8,696
-11,610
-26,953
-10,862
-2,690
Normalized Income
-8,696
-11,610
-28,409
-10,862
-2,690
Interest Expense
-
0
774.679
706.446
0
Net Interest Income
-
0
-774.679
-706.446
0
EBIT
-9,343
-11,715
-26,179
-10,156
-2,690
EBITDA
-9,342
-11,713
-26,177
-10,154
-2,689
Reconciled Depreciation
1.102
1.728
1.5
1.44
0.664
Net Income from Continuing Operation Net Minority Interest
-8,696
-11,610
-26,953
-10,862
-2,690
Total Unusual Items Excluding Goodwill
-
-
1,456
-
-
Total Unusual Items
-
-
1,456
-
-
Normalized EBITDA
-9,342
-11,713
-27,633
-10,154
-2,689
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0